Notably, the viability of oxU87 cells decreased more significantly in the post-treatment phase than in the treatment phase (p < 0.001), suggesting that overexpressing PDCD10 largely prevented the restoration of GBM cell regrowth capacity in the post-treatment phase. Here, PDCD10 is linked to glioblastoma.